Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2009, Article ID 748174, 11 pages
http://dx.doi.org/10.1155/2009/748174
Review Article

Peroxisome Proliferator-Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease

1Gastroenterology Unit, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50134 Firenze, Italy
2FiorGen Farmacogenomic Foundation, Via Luigi Sacconi 6, 50019 Firenze, Italy

Received 31 January 2009; Revised 19 May 2009; Accepted 13 July 2009

Academic Editor: James P. Hardwick

Copyright © 2009 Tommaso Mello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Surrenti and A. Galli, “Molecular mechanisms of alcohol-induced liver injury: an update,” Minerva Gastroenterologica e Dietologica, vol. 49, no. 2, pp. 95–105, 2003. View at Google Scholar
  2. M. Sozio and D. W. Crabb, “Alcohol and lipid metabolism,” American Journal of Physiology, vol. 295, no. 1, pp. E10–E16, 2008. View at Publisher · View at Google Scholar
  3. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “hits”?” Gastroenterology, vol. 114, no. 4, pp. 842–845, 1998. View at Publisher · View at Google Scholar
  4. T. M. Donohue Jr., “Alcohol-induced steatosis in liver cells,” World Journal of Gastroenterology, vol. 13, no. 37, pp. 4974–4978, 2007. View at Google Scholar
  5. C. S. Lieber, “Hepatic, metabolic and toxic effects of ethanol: 1991 update,” Alcoholism: Clinical and Experimental Research, vol. 15, no. 4, pp. 573–592, 1991. View at Google Scholar
  6. C. S. Lieber and L. M. DeCarli, “Hepatotoxicity of ethanol,” Journal of Hepatology, vol. 12, no. 3, pp. 394–401, 1991. View at Google Scholar
  7. A. Galli, D. Price, and D. Crabb, “High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced HeLa cells,” Hepatology, vol. 29, no. 4, pp. 1164–1170, 1999. View at Google Scholar
  8. S. M. Bailey and C. C. Cunningham, “Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes,” Hepatology, vol. 28, no. 5, pp. 1318–1326, 1998. View at Publisher · View at Google Scholar
  9. T. D. Lee, M. R. Sadda, M. H. Mendler et al., “Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis,” Alcoholism: Clinical and Experimental Research, vol. 28, no. 1, pp. 173–181, 2004. View at Publisher · View at Google Scholar
  10. T. Dai, Y. Wu, A.-S. Leng et al., “RXRa-regulated liver SAMe and GSH levels influence susceptibility to alcohol-induced hepatotoxicity,” Experimental and Molecular Pathology, vol. 75, no. 3, pp. 194–200, 2003. View at Publisher · View at Google Scholar
  11. G. Dai, N. Chou, L. He et al., “Retinoid X receptor a regulates the expression of glutathione S-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver,” Molecular Pharmacology, vol. 68, no. 6, pp. 1590–1596, 2005. View at Publisher · View at Google Scholar
  12. M. A. Gyamfi, M. G. Kocsis, L. He, G. Dai, A. J. Mendy, and Y.-J. Y. Wan, “The role of retinoid X receptor α in regulating alcohol metabolism,” Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 360–368, 2006. View at Publisher · View at Google Scholar
  13. C. Bode and J. C. Bode, “Effect of alcohol consumption on the gut,” Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 17, no. 4, pp. 575–592, 2003. View at Publisher · View at Google Scholar
  14. A. Keshavarzian, E. W. Holmes, M. Patel, F. Iber, J. Z. Fields, and S. Pethkar, “Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage,” American Journal of Gastroenterology, vol. 94, no. 1, pp. 200–207, 1999. View at Publisher · View at Google Scholar
  15. Y. Tang, A. Banan, C. B. Forsyth et al., “Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 32, no. 2, pp. 355–364, 2008. View at Publisher · View at Google Scholar
  16. A. Keshavarzian and J. Fields, “Alcoholic liver disease: is it an “extraintestinal” complication of alcohol-induced intestinal injury?” Journal of Laboratory and Clinical Medicine, vol. 142, no. 5, pp. 285–287, 2003. View at Publisher · View at Google Scholar
  17. R. K. Rao, “Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer,” Methods in Molecular Biology, vol. 447, pp. 171–183, 2008. View at Google Scholar
  18. X. Han, M. P. Fink, R. Yang, and R. L. Delude, “Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice,” Shock, vol. 21, no. 3, pp. 261–270, 2004. View at Google Scholar
  19. Y. Tang, C. B. Forsyth, A. Farhadi et al., “Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage,” Alcoholism: Clinical and Experimental Research, vol. 33, no. 7, pp. 1220–1230, 2009. View at Publisher · View at Google Scholar
  20. A. Banan, J. Z. Fields, H. Decker, Y. Zhang, and A. Keshavarzian, “Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction,” Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 3, pp. 997–1008, 2000. View at Google Scholar
  21. Y. Adachi, B. U. Bradford, W. Gao, H. K. Bojes, and R. G. Thurman, “Inactivation of Kupffer cells prevents early alcohol-induced liver injury,” Hepatology, vol. 20, no. 2, pp. 453–460, 1994. View at Publisher · View at Google Scholar
  22. T. Gustot, A. Lemmers, C. Moreno et al., “Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver,” Hepatology, vol. 43, no. 5, pp. 989–1000, 2006. View at Publisher · View at Google Scholar
  23. K. Nagata, H. Suzuki, and S. Sakaguchi, “Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis,” Journal of Toxicological Sciences, vol. 32, no. 5, pp. 453–468, 2007. View at Publisher · View at Google Scholar
  24. Q. Cao, K. M. Mak, and C. S. Lieber, “Cytochrome P4502E1 primes macrophages to increase TNF-α production in response to lipopolysaccharide,” American Journal of Physiology, vol. 289, no. 1, pp. G95–G107, 2005. View at Publisher · View at Google Scholar
  25. S. Naveau, G. Perlemuter, M. Chaillet et al., “Serum leptin in patients with alcoholic liver disease,” Alcoholism: Clinical and Experimental Research, vol. 30, no. 8, pp. 1422–1428, 2006. View at Publisher · View at Google Scholar
  26. Q. Cao, K. M. Mak, and C. S. Lieber, “Leptin enhances α1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways,” Journal of Cellular Biochemistry, vol. 97, no. 1, pp. 188–197, 2006. View at Publisher · View at Google Scholar
  27. J. García-Villafranca, A. Guillén, and J. Castro, “Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver,” Biochimie, vol. 90, no. 3, pp. 460–466, 2008. View at Publisher · View at Google Scholar
  28. A. Galli, J. Pinaire, M. Fischer, R. Dorris, and D. W. Crabb, “The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor α is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver,” The Journal of Biological Chemistry, vol. 276, no. 1, pp. 68–75, 2001. View at Publisher · View at Google Scholar
  29. M. Fischer, M. You, M. Matsumoto, and D. W. Crabb, “Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice,” The Journal of Biological Chemistry, vol. 278, no. 30, pp. 27997–28004, 2003. View at Publisher · View at Google Scholar
  30. C. S. Lieber, M. A. Leo, X. Wang, and L. M. DeCarli, “Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1α in rats,” Biochemical and Biophysical Research Communications, vol. 370, no. 1, pp. 44–48, 2008. View at Publisher · View at Google Scholar
  31. C. S. Lieber, M. A. Leo, X. Wang, and L. M. DeCarli, “Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function,” Biochemical and Biophysical Research Communications, vol. 373, no. 2, pp. 246–252, 2008. View at Publisher · View at Google Scholar
  32. M. You, M. Fischer, M. A. Deeg, and D. W. Crabb, “Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP),” The Journal of Biological Chemistry, vol. 277, no. 32, pp. 29342–29347, 2002. View at Google Scholar
  33. M. You, X. Liang, J. M. Ajmo, and G. C. Ness, “Involvement of mammalian sirtuin 1 in the action of ethanol in the liver,” American Journal of Physiology, vol. 294, no. 4, pp. G892–G898, 2008. View at Publisher · View at Google Scholar
  34. M. You, Q. Cao, X. Liang, J. M. Ajmo, and G. C. Ness, “Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice,” Journal of Nutrition, vol. 138, no. 3, pp. 497–501, 2008. View at Google Scholar
  35. J. M. Ajmo, X. Liang, C. Q. Rogers, B. Pennock, and M. You, “Resveratrol alleviates alcoholic fatty liver in mice,” American Journal of Physiology, vol. 295, no. 4, pp. G833–G842, 2008. View at Publisher · View at Google Scholar
  36. S.-I. Imai, C. M. Armstrong, M. Kaeberlein, and L. Guarente, “Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase,” Nature, vol. 403, no. 6771, pp. 795–800, 2000. View at Publisher · View at Google Scholar
  37. H. Vaziri, S. K. Dessain, E. N. Eaton et al., “hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase,” Cell, vol. 107, no. 2, pp. 149–159, 2001. View at Publisher · View at Google Scholar
  38. S. Nemoto, M. M. Fergusson, and T. Finkel, “SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α,” The Journal of Biological Chemistry, vol. 280, no. 16, pp. 16456–16460, 2005. View at Publisher · View at Google Scholar
  39. J. T. Rodgers, C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver, “Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1,” Nature, vol. 434, no. 7029, pp. 113–118, 2005. View at Publisher · View at Google Scholar
  40. J. T. Rodgers and P. Puigserver, “Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 31, pp. 12861–12866, 2007. View at Publisher · View at Google Scholar
  41. T. Nakajima, Y. Kamijo, N. Tanaka et al., “Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage,” Hepatology, vol. 40, no. 4, pp. 972–980, 2004. View at Publisher · View at Google Scholar
  42. Y.-J. Y. Wan, M. Morimoto, R. G. Thurman, H. K. Bojes, and S. W. French, “Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease,” Life Sciences, vol. 56, no. 5, pp. 307–317, 1995. View at Publisher · View at Google Scholar
  43. A. A. Nanji, A. J. Dannenberg, K. Jokelainen, and N. M. Bass, “Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-α (PPARα)-regulated genes and is ameliorated by PPARα activation,” Journal of Pharmacology and Experimental Therapeutics, vol. 310, no. 1, pp. 417–424, 2004. View at Publisher · View at Google Scholar
  44. S. S.-T. Lee and F. J. Gonzalez, “Targeted disruption of the peroxisome proliferator-activated receptor α gene, PPARα,” Annals of the New York Academy of Sciences, vol. 804, pp. 524–529, 1996. View at Publisher · View at Google Scholar
  45. S. S.-T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar
  46. T. Aoyama, J. M. Peters, N. Iritani et al., “Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor a (PPARa),” The Journal of Biological Chemistry, vol. 273, no. 10, pp. 5678–5684, 1998. View at Publisher · View at Google Scholar
  47. N. Tanaka, K. Hora, H. Makishima et al., “In vivo stabilization of nuclear retinoid X receptor a in the presence of peroxisome proliferator-activated receptor a,” FEBS Letters, vol. 543, no. 1–3, pp. 120–124, 2003. View at Publisher · View at Google Scholar
  48. P. R. Devchand, H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli, “The PPARα-leukotriene B4 pathway to inflammation control,” Nature, vol. 384, no. 6604, pp. 39–43, 1996. View at Publisher · View at Google Scholar
  49. G. Chinetti, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications,” International Journal of Obesity, vol. 27, supplement 3, pp. S41–S45, 2003. View at Publisher · View at Google Scholar
  50. A. Galli, D. Crabb, D. Price et al., “Peroxisome proliferator-activated receptor ? transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells,” Hepatology, vol. 31, no. 1, pp. 101–108, 2000. View at Google Scholar
  51. F. Marra, E. Efsen, R. G. Romanelli et al., “Ligands of peroxisome proliferator-activated receptor ? modulate profibrogenic and proinflammatory actions in hepatic stellate cells,” Gastroenterology, vol. 119, no. 2, pp. 466–478, 2000. View at Google Scholar
  52. T. Miyahara, L. Schrum, R. Rippe et al., “Peroxisome proliferator-activated receptors and hepatic stellate cell activation,” The Journal of Biological Chemistry, vol. 275, no. 46, pp. 35715–35722, 2000. View at Publisher · View at Google Scholar
  53. A. Galli, D. W. Crabb, E. Ceni et al., “Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro,” Gastroenterology, vol. 122, no. 7, pp. 1924–1940, 2002. View at Google Scholar
  54. E. Ceni, D. W. Crabb, M. Foschi et al., “Acetaldehyde inhibits PPAR? via H2O2-mediated c-Abl activation in human hepatic stellate cells,” Gastroenterology, vol. 131, no. 4, pp. 1235–1252, 2006. View at Publisher · View at Google Scholar
  55. P. Greenwel, J.-A. Domínguez-Rosales, G. Mavi, A. M. Rivas-Estilla, and M. Rojkind, “Hydrogen peroxide: a link between acetaldehyde-elicited α1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells,” Hepatology, vol. 31, no. 1, pp. 109–116, 2000. View at Google Scholar
  56. G. Svegliati-Baroni, F. Ridolfi, A. Di Sario et al., “Intracellular signaling pathways involved in acetaldehyde-induced collagen and fibronectin gene expression in human hepatic stellate cells,” Hepatology, vol. 33, no. 5, pp. 1130–1140, 2001. View at Publisher · View at Google Scholar
  57. G. Novitskiy, K. Traore, L. Wang, M. A. Trush, and E. Mezey, “Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells,” Alcoholism: Clinical and Experimental Research, vol. 30, no. 8, pp. 1429–1435, 2006. View at Publisher · View at Google Scholar
  58. N. Nieto, “Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells,” Hepatology, vol. 44, no. 6, pp. 1487–1501, 2006. View at Google Scholar
  59. N. Enomoto, Y. Takei, M. Hirose et al., “Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-?, pioglitazone,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 846–854, 2003. View at Publisher · View at Google Scholar
  60. M. Ohata, H. Suzuki, K. Sakamoto et al., “Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-a,” Alcoholism: Clinical and Experimental Research, vol. 28, no. 8, supplement, pp. 139S–144S, 2004. View at Publisher · View at Google Scholar
  61. Y. Nakamura, H. Yokoyama, Y. Okamura et al., “Evidence for ethanol oxidation by Kupffer cells,” Alcoholism: Clinical and Experimental Research, vol. 23, no. 4, supplement, pp. 92S–95S, 1999. View at Google Scholar
  62. D. R. Koop, A. Chernosky, and E. P. Brass, “Identification and induction of cytochrome P450 2E1 in rat Kupffer cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 258, no. 3, pp. 1072–1076, 1991. View at Google Scholar
  63. T. Koivisto, V. M. Mishin, K. M. Mak, P. A. Cohen, and C. S. Lieber, “Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells,” Alcoholism: Clinical and Experimental Research, vol. 20, no. 2, pp. 207–212, 1996. View at Publisher · View at Google Scholar
  64. Y. Nakamura, H. Yokoyama, S. Higuchi, S. Hara, S. Kato, and H. Ishii, “Acetaldehyde accumulation suppresses Kupffer cell release of TNF-α and modifies acute hepatic inflammation in rats,” Journal of Gastroenterology, vol. 39, no. 2, pp. 140–147, 2004. View at Publisher · View at Google Scholar
  65. K. O. Lindros, K. Jokelainen, and A. A. Nanji, “Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats,” Laboratory Investigation, vol. 79, no. 7, pp. 799–806, 1999. View at Google Scholar
  66. Q. Cao, K. M. Mak, and C. S. Lieber, “Dilinoleoylphosphatidylcholine decreases acetaldehyde-induced TNF-α generation in Kupffer cells of ethanol-fed rats,” Biochemical and Biophysical Research Communications, vol. 299, no. 3, pp. 459–464, 2002. View at Publisher · View at Google Scholar
  67. Q. Cao, K. M. Mak, and C. S. Lieber, “Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-α generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-κB,” Biochemical and Biophysical Research Communications, vol. 294, no. 4, pp. 849–853, 2002. View at Publisher · View at Google Scholar
  68. G. L. Su, R. D. Klein, A. Aminlari et al., “Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and Toll-like receptor 4,” Hepatology, vol. 31, no. 4, pp. 932–936, 2000. View at Google Scholar
  69. G. L. Su, “Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation,” American Journal of Physiology, vol. 283, no. 2, pp. G256–G265, 2002. View at Google Scholar
  70. S. Yamashina, Y. Takei, K. Ikejima, N. Enomoto, T. Kitamura, and N. Sato, “Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress,” Alcoholism: Clinical and Experimental Research, vol. 29, no. 12, supplement, pp. 246S–250S, 2005. View at Publisher · View at Google Scholar
  71. J. Ye, “Regulation of PPARγ function by TNF-α,” Biochemical and Biophysical Research Communications, vol. 374, no. 3, pp. 405–408, 2008. View at Publisher · View at Google Scholar
  72. M. Zhou, R. Wu, W. Dong, A. Jacob, and P. Wang, “Endotoxin downregulates peroxisome proliferator-activated receptor-γ via the increase in TNF-α release,” American Journal of Physiology, vol. 294, no. 1, pp. R84–R92, 2008. View at Publisher · View at Google Scholar
  73. B. M. Necela, W. Su, and E. A. Thompson, “Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor γ and nuclear factor-κB in macrophages,” Immunology, vol. 125, no. 3, pp. 344–358, 2008. View at Publisher · View at Google Scholar
  74. T. E. Cullingford, K. Bhakoo, S. Peuchen, C. T. Dolphin, R. Patel, and J. B. Clark, “Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β, and γ and the retinoid X receptor α, β, and γ in rat central nervous system,” Journal of Neurochemistry, vol. 70, no. 4, pp. 1366–1375, 1998. View at Google Scholar
  75. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
  76. U. Seedorf and J. Aberle, “Emerging roles of PPARδ in metabolism,” Biochimica et Biophysica Acta, vol. 1771, no. 9, pp. 1125–1131, 2007. View at Publisher · View at Google Scholar
  77. E. Bedu, W. Wahli, and B. Desvergne, “Peroxisome proliferator-activated receptor β/δ as a therapeutic target for matabolic diseases,” Expert Opinion on Therapeutic Targets, vol. 9, no. 4, pp. 861–873, 2005. View at Publisher · View at Google Scholar
  78. K. Hellemans, K. Rombouts, E. Quartier et al., “PPARß regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation,” Journal of Lipid Research, vol. 44, no. 2, pp. 280–295, 2003. View at Publisher · View at Google Scholar
  79. K. Hellemans, L. Michalik, A. Dittie et al., “Peroxisome proliferator-activated receptor-ß signaling contributes to enhanced proliferation of hepatic stellate cells,” Gastroenterology, vol. 124, no. 1, pp. 184–201, 2003. View at Publisher · View at Google Scholar
  80. M. Pang, S. M. de la Monte, L. Longato et al., “PPARd agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair,” Journal of Hepatology, vol. 50, no. 6, pp. 1192–1201, 2009. View at Publisher · View at Google Scholar
  81. Y. Sasaki, N. Hayashi, T. Ito, H. Fusamoto, T. Kamada, and J. R. Wands, “Influence of ethanol on insulin receptor substrate-1-mediated signal transduction during rat liver regeneration,” Alcohol and Alcoholism, vol. 29, supplement 1, pp. 99–106, 1994. View at Google Scholar
  82. Y. Sasaki and J. R. Wands, “Ethanol impairs insulin receptor substrate-1 mediated signal transduction during rat liver regeneration,” Biochemical and Biophysical Research Communications, vol. 199, no. 1, pp. 403–409, 1994. View at Publisher · View at Google Scholar
  83. M. K. H. Hsu, L. Qiao, V. Ho et al., “Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats,” Journal of Hepatology, vol. 44, no. 2, pp. 375–382, 2006. View at Publisher · View at Google Scholar
  84. H. Poso, H. Vaananen, M. P. Salaspuro, and A. R. Poso, “Effects of ethanol on liver regeneration after partial hepatectomy in rats,” Medical Biology, vol. 58, no. 6, pp. 329–336, 1980. View at Google Scholar
  85. C.-H. Lee, P. Olson, A. Hevener et al., “PPARd regulates glucose metabolism and insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3444–3449, 2006. View at Publisher · View at Google Scholar
  86. K. Kang, S. M. Reilly, V. Karabacak et al., “Adipocyte-derived Th2 cytokines and myeloid PPARd regulate macrophage polarization and insulin sensitivity,” Cell Metabolism, vol. 7, no. 6, pp. 485–495, 2008. View at Publisher · View at Google Scholar
  87. J. I. Odegaard, R. R. Ricardo-Gonzalez, A. Red Eagle et al., “Alternative M2 activation of Kupffer cells by PPARd ameliorates obesity-induced insulin resistance,” Cell Metabolism, vol. 7, no. 6, pp. 496–507, 2008. View at Publisher · View at Google Scholar
  88. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth et al., “Macrophage-specific PPAR? controls alternative activation and improves insulin resistance,” Nature, vol. 447, no. 7148, pp. 1116–1120, 2007. View at Publisher · View at Google Scholar
  89. J. M. Peters, I. Rusyn, M. L. Rose, F. J. Gonzalez, and R. G. Thurman, “Peroxisome proliferator-activated receptor α is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis,” Carcinogenesis, vol. 21, no. 4, pp. 823–826, 2000. View at Google Scholar
  90. A. V. Leisewitz, J. E. Jung, P. Perez-Alzola et al., “Ethanol specifically decreases peroxisome proliferator activated receptor ß in B12 oligodendrocyte-like cells,” Journal of Neurochemistry, vol. 85, no. 1, pp. 135–141, 2003. View at Google Scholar
  91. E. R. Sowell, S. N. Mattson, P. M. Thompson, T. L. Jernigan, E. P. Riley, and A. W. Toga, “Mapping callosal morphology and cognitive correlates: effects of heavy prenatal alcohol exposure,” Neurology, vol. 57, no. 2, pp. 235–244, 2001. View at Google Scholar
  92. N. G. Venkata, C. S. Aung, P. J. Cabot, G. R. Monteith, and S. J. Roberts-Thomson, “PPARα and PPARβ are differentially affected by ethanol and the ethanol metabolite acetaldehyde in the MCF-7 breast cancer cell line,” Toxicological Sciences, vol. 102, no. 1, pp. 120–128, 2008. View at Publisher · View at Google Scholar
  93. K. W. Singletary and S. M. Gapstur, “Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms,” Journal of the American Medical Association, vol. 286, no. 17, pp. 2143–2151, 2001. View at Google Scholar
  94. R. Baan, K. Straif, Y. Grosse et al., “Carcinogenicity of alcoholic beverages,” The Lancet Oncology, vol. 8, no. 4, pp. 292–293, 2007. View at Publisher · View at Google Scholar
  95. D. J. Mangelsdorf, U. Borgmeyer, R. A. Heyman et al., “Characterization of three RXR genes that mediate the action of 9-cis retinoic acid,” Genes & Development, vol. 6, no. 3, pp. 329–344, 1992. View at Google Scholar
  96. W. Krezel, V. Dupé, M. Mark, A. Dierich, P. Kastner, and P. Chambon, “RXRγ null mice are apparently normal and compound RXRα+/-/RXRβ-/-/RXRγ-/-mutant mice are viable,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 17, pp. 9010–9014, 1996. View at Google Scholar
  97. D. W. Crabb, A. Galli, M. Fischer, and M. You, “Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha,” Alcohol, vol. 34, no. 1, pp. 35–38, 2004. View at Publisher · View at Google Scholar
  98. Y.-J. Y. Wan, G. Han, Y. Cai, T. Dai, T. Konishi, and A.-S. Leng, “Hepatocyte retinoid X receptor-α-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance,” Endocrinology, vol. 144, no. 2, pp. 605–611, 2003. View at Publisher · View at Google Scholar
  99. E. Mezey, L. Rennie-Tankersley, and J. J. Potter, “Effect of leptin on liver alcohol dehydrogenase,” Biochemical and Biophysical Research Communications, vol. 337, no. 4, pp. 1324–1329, 2005. View at Publisher · View at Google Scholar
  100. D. J. Waxman, “P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR,” Archives of Biochemistry and Biophysics, vol. 369, no. 1, pp. 11–23, 1999. View at Publisher · View at Google Scholar
  101. A. P. Beigneux, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold, “The acute phase response is associated with retinoid X receptor repression in rodent liver,” The Journal of Biological Chemistry, vol. 275, no. 21, pp. 16390–16399, 2000. View at Publisher · View at Google Scholar
  102. T. H. Rushmore and A.-N. T. Kong, “Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes,” Current Drug Metabolism, vol. 3, no. 5, pp. 481–490, 2002. View at Publisher · View at Google Scholar
  103. Y. Cai, T. Konishi, G. Han, K. H. Campwala, S. W. French, and Y.-J. Y. Wan, “The role of hepatocyte RXRα in xenobiotic-sensing nuclear receptor-mediated pathways,” European Journal of Pharmaceutical Sciences, vol. 15, no. 1, pp. 89–96, 2002. View at Publisher · View at Google Scholar
  104. E. F. Johnson, M.-H. Hsu, U. Savas, and K. J. Griffin, “Regulation of P450 4A expression by peroxisome proliferator activated receptors,” Toxicology, vol. 181-182, pp. 203–206, 2002. View at Publisher · View at Google Scholar
  105. N. J. Cherrington, A. L. Slitt, J. M. Maher et al., “Induction of multidrug resistance protein 3 (MRP3) in vivo is independent of constitutive androstane receptor,” Drug Metabolism and Disposition, vol. 31, no. 11, pp. 1315–1319, 2003. View at Publisher · View at Google Scholar
  106. Y. Cai, T. Dai, Y. Ao et al., “Cytochrome P450 genes are differentially expressed in female and male hepatocyte retinoid X receptor a-deficient mice,” Endocrinology, vol. 144, no. 6, pp. 2311–2318, 2003. View at Publisher · View at Google Scholar
  107. M. A. Gyamfi, L. He, S. W. French, I. Damjanov, and Y.-J. Y. Wan, “Hepatocyte retinoid X receptor α-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 2, pp. 443–453, 2008. View at Publisher · View at Google Scholar
  108. R. K. Chawla, W. H. Watson, C. E. Eastin, E. Y. Lee, J. Schmidt, and C. J. Mcclain, “S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury,” American Journal of Physiology, vol. 275, no. 1, part 1, pp. G125–G129, 1998. View at Google Scholar
  109. M. A. Gyamfi and Y.-J. Y. Wan, “The effect of ethanol, ethanol metabolizing enzyme inhibitors, and Vitamin E on regulating glutathione, glutathione S-transferase, and S-adenosylmethionine in mouse primary hepatocyte,” Hepatology Research, vol. 35, no. 1, pp. 53–61, 2006. View at Publisher · View at Google Scholar
  110. R. C. Strange, M. A. Spiteri, S. Ramachandran, and A. A. Fryer, “Glutathione-S-transferase family of enzymes,” Mutation Research, vol. 482, no. 1-2, pp. 21–26, 2001. View at Google Scholar
  111. E. Y. Park, I. J. Cho, and S. G. Kim, “Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-γ and retinoid X receptor heterodimer,” Cancer Research, vol. 64, no. 10, pp. 3701–3713, 2004. View at Publisher · View at Google Scholar
  112. S. S. Singhal, M. Saxena, H. Ahmad, S. Awasthi, A. K. Haque, and Y. C. Awasthi, “Glutathione S-transferases of human lung: characterization and evaluation of the protective role of the α-class isozymes against lipid peroxidation,” Archives of Biochemistry and Biophysics, vol. 299, no. 2, pp. 232–241, 1992. View at Publisher · View at Google Scholar
  113. Y. Yang, J.-Z. Cheng, S. S. Singhal et al., “Role of glutathione S-transferases in protection against lipid peroxidation: overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation,” The Journal of Biological Chemistry, vol. 276, no. 22, pp. 19220–19230, 2001. View at Publisher · View at Google Scholar
  114. Y. Yang, R. Sharma, P. Zimniak, and Y. C. Awasthi, “Role of α class glutathione S-transferases as antioxidant enzymes in rodent tissues,” Toxicology and Applied Pharmacology, vol. 182, no. 2, pp. 105–115, 2002. View at Publisher · View at Google Scholar
  115. Y. Yang, R. Sharma, J.-Z. Cheng et al., “Protection of HLE B-3 cells against hydrogen peroxide- and naphthalene-induced lipid peroxidation and apoptosis by transfection with hGSTA1 and hGSTA2,” Investigative Ophthalmology and Visual Science, vol. 43, no. 2, pp. 434–445, 2002. View at Google Scholar
  116. D. W. Crabb and S. Liangpunsakul, “Alcohol and lipid metabolism,” Journal of Gastroenterology and Hepatology, vol. 21, supplement 3, pp. S56–S60, 2006. View at Publisher · View at Google Scholar
  117. M. You and D. W. Crabb, “Recent advances in alcoholic liver disease. II. Minireview: molecular mechanisms of alcoholic fatty liver,” American Journal of Physiology, vol. 287, no. 1, pp. G1–G6, 2004. View at Publisher · View at Google Scholar
  118. Y.-J. Y. Wan, Y. Cai, W. Lungo et al., “Peroxisome proliferator-activated receptor a-mediated pathways are altered in hepatocyte-specific retinoid X receptor a-deficient mice,” The Journal of Biological Chemistry, vol. 275, no. 36, pp. 28285–28290, 2000. View at Publisher · View at Google Scholar
  119. U. Razny, L. Wator, A. Polus et al., “Hepatocyte RXR alpha deletion in mice leads to inhibition of angiogenesis,” Genes and Nutrition, vol. 4, no. 1, pp. 69–72, 2009. View at Publisher · View at Google Scholar
  120. M. S. Kim, T. R. Sweeney, J. K. Shigenaga et al., “Tumor necrosis factor and interleukin 1 decrease RXRa, PPARa, PPAR?, LXRa, and the coactivators SRC-1, PGC-1a, and PGC-1ß in liver cells,” Metabolism, vol. 56, no. 2, pp. 267–279, 2007. View at Publisher · View at Google Scholar
  121. D. Li, T. L. Zimmerman, S. Thevananther, H.-Y. Lee, J. M. Kurie, and S. J. Karpen, “Interleukin-1β-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent,” The Journal of Biological Chemistry, vol. 277, no. 35, pp. 31416–31422, 2002. View at Publisher · View at Google Scholar
  122. R. Ghose, T. L. Zimmerman, S. Thevananther, and S. J. Karpen, “Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: a novel mechanism for reduced hepatic gene expression in inflammation,” Nuclear Receptor, vol. 2, no. 1, article 4, 2004. View at Publisher · View at Google Scholar
  123. T. L. Zimmerman, S. Thevananther, R. Ghose, A. R. Burns, and S. J. Karpen, “Nuclear export of retinoid X receptor α in response to interleukin-1β-mediated cell signaling: roles for JNK and SER260,” The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15434–15440, 2006. View at Publisher · View at Google Scholar
  124. H. K. Seitz, “Alcohol and retinoid metabolism,” Gut, vol. 47, no. 6, pp. 748–750, 2000. View at Publisher · View at Google Scholar
  125. V. López-Valencia, P. Rangel, S. Rodríguez, and R. Hernández-Muñoz, “Involvement of alcohol and aldehyde dehydrogenase activities on hepatic retinoid metabolism and its possible participation in the progression of rat liver regeneration,” Biochemical Pharmacology, vol. 73, no. 4, pp. 586–596, 2007. View at Publisher · View at Google Scholar
  126. H. Friedman, S. Mobarhan, J. Hupert et al., “In vitro stimulation of rat liver retinyl ester hydrolase by ethanol,” Archives of Biochemistry and Biophysics, vol. 269, no. 1, pp. 69–74, 1989. View at Google Scholar
  127. C. Liu, J. Chung, H. K. Seitz, R. M. Russell, and X.-D. Wang, “Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats,” Alcoholism: Clinical and Experimental Research, vol. 26, no. 11, pp. 1703–1709, 2002. View at Google Scholar
  128. T. Mello, A. Nakatsuka, S. Fears et al., “Expression of carboxylesterase and lipase genes in rat liver cell-types,” Biochemical and Biophysical Research Communications, vol. 374, no. 3, pp. 460–464, 2008. View at Publisher · View at Google Scholar